Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-03

FDA Approved: CELECOXIB — Original Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original ANDA for Celecoxib from ScieGen Pharmaceuticals, a generic version of the COX-2 inhibitor used for pain relief. It covers common uses …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)

Snippet

ORIG AP for CELECOXIB (CELECOXIB)